Clinical Trials Browser

Interventional × BO-112 × Clear all

NCT06422936 2026-01-26

SPOTLIGHT204

Phase 2 Active not recruiting

Carcinoma, Basal Cell

NCT04570332 2025-11-26

SPOTLIGHT203

Phase 2 Completed

42 enrolled 12 charts

Melanoma

NCT04508140 2024-11-29

Study of BO-112 With Pembrolizumab for Colorectal or Gastric/GEJ Cancer With Liver Metastasis

Phase 2 Terminated

18 enrolled 13 charts

Gastrointestinal

Esophageal Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT04777708 2023-03-24

BO-112 and Pembrolizumab for the Treatment of PD-1/PD-L1 Refractory Liver Cancer

Phase EARLY_PHASE1 Terminated

Gastrointestinal

Carcinoma, Hepatocellular

NCT05265650 2022-07-19

Noelia

Phase 1/2 Unknown

Non-Small Cell Lung Cancer Metastatic